NCT06291610

Brief Summary

A decision-support intervention are developed for a Danish nationwide randomised controlled trial (RCT) among patients with laryngeal and pharyngeal cancer referred to curative intended radiotherapy. The primary endpoints in this RCT are levels of dysphagia and xerostomia. The decision-support intervention consists of three components, including (1) a patient decision aid tailored to clinical trial participation and (2) decision coaching consultations carried out by trained healthcare professionals. Finally, (3) a training program in decision coaching will be an integrated part of the intervention. To feasibility test (beta test) the intervention, 60 patient participants will be included, separated into pre- (n=30) and post- (n=30) intervention groups. Pre-intervention to complete the survey based on current clinical practice. Post-intervention to complete the survey following engagement in the decision support intervention. A total of 12 physicians will be recruited and trained in decision coaching. To assess the acceptability of the intervention, the physicians will be interviewed. Additionally, they will be asked to audio-record two decision coaching sessions to test the fidelity of the intervention.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
5mo left

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Feb 2024Dec 2026

First Submitted

Initial submission to the registry

February 8, 2024

Completed
11 days until next milestone

Study Start

First participant enrolled

February 19, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 4, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

March 4, 2024

Status Verified

February 1, 2024

Enrollment Period

1.9 years

First QC Date

February 8, 2024

Last Update Submit

February 26, 2024

Conditions

Keywords

Clinical trial decision makingPatient involvementDecision coachingFeasibility studyComplex intervention

Outcome Measures

Primary Outcomes (2)

  • Decisional conflict scale

    Measures the level of patients decisional conflict

    The day of signing the clinical trial consent form

  • The decision preparation scale

    Measures patients ability to prepare for decision-making

    The day of signing the clinical trial consent form

Secondary Outcomes (2)

  • The stages of decision making measure

    The day of signing the clinical trial consent form

  • Items on health literacy

    The day of signing the clinical trial consent form

Study Arms (1)

Decision intervention group

OTHER

The decision intervention will be tested in one arm (group)

Behavioral: Clinical trial decision support intervention

Interventions

1. a patient decision aid tailored to clinical trial participation 2. decision coaching consultations carried out by trained healthcare professionals. 3. a training program in decision coaching will be an integrated part of the intervention.

Decision intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with cancer of the pharynx or larynx
  • Received verbal information regarding DAHANCA 35
  • Read the patient information folder from DAHANCA 35
  • Above 18 years
  • Danish speaking

You may not qualify if:

  • Dyslexia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University Hospital

Aarhus, 8200, Denmark

RECRUITING

MeSH Terms

Conditions

Head and Neck NeoplasmsPatient Participation

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Anne W Kristensen, MSc

    Aarhus University Hospital

    STUDY CHAIR
  • Cai W Grau, Professor

    Aarhus University Hospital

    STUDY DIRECTOR
  • Jeppe Friborg, MD, PhD

    Rigshospitalet, Denmark

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anne Kristensen, MSc

CONTACT

Cai Grau, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Patients are recruited anonymous
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Pre- and post-intervention measures in two consecutive groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2024

First Posted

March 4, 2024

Study Start

February 19, 2024

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

March 4, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations